Sven Mahner
Sven Mahner
Verified email at - Homepage
Cited by
Cited by
Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer
MR Mirza, BJ Monk, J Herrstedt, AM Oza, S Mahner, A Redondo, ...
New England Journal of Medicine 375 (22), 2154-2164, 2016
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
AM Oza, D Cibula, AO Benzaquen, C Poole, RHJ Mathijssen, GS Sonke, ...
The lancet oncology 16 (1), 87-97, 2015
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Marth, F Landoni, S Mahner, M McCormack, A Gonzalez-Martin, ...
Annals of Oncology 28 (suppl_4), iv72-iv83, 2017
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission …
P Harter, J Sehouli, A Reuss, A Hasenburg, G Scambia, D Cibula, ...
International Journal of Gynecologic Cancer 21 (2), 2011
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F] fluorodeoxyglucose
J Schwarz-Dose, M Untch, R Tiling, S Sassen, S Mahner, S Kahlert, ...
J Clin Oncol 27 (4), 535-41, 2009
Borderline tumours of the ovary: a cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group
A du Bois, N Ewald-Riegler, N de Gregorio, A Reuss, S Mahner, ...
European Journal of cancer 49 (8), 1905-1914, 2013
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+ CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
D Chen, Y Zhang, J Wang, J Chen, C Yang, K Cai, X Wang, F Shi, J Dou
Journal of ovarian research 6 (1), 1-11, 2013
A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms
P Harter, J Sehouli, D Lorusso, A Reuss, I Vergote, C Marth, JW Kim, ...
New England Journal of Medicine 380 (9), 822-832, 2019
Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of …
S Mahner, S Schirrmacher, W Brenner, L Jenicke, CR Habermann, N Avril, ...
Annals of oncology 19 (7), 1249-1254, 2008
adjuvant therapy in lymph node–positive vulvar cancer: the AGO-CaRE-1 study
S Mahner, J Jueckstock, F Hilpert, P Neuser, P Harter, N de Gregorio, ...
JNCI: Journal of the National Cancer Institute 107 (3), 2015
C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
S Mahner, C Baasch, J Schwarz, S Hein, L Wölber, F Jänicke, ...
British journal of cancer 99 (8), 1269-1275, 2008
Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP)
N Duesing, J Schwarz, M Choschzick, F Jaenicke, F Gieseking, R Issa, ...
Archives of gynecology and obstetrics 286 (6), 1549-1554, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance—a study of the OVCAD consortium
E Obermayr, DC Castillo-Tong, D Pils, P Speiser, I Braicu, T Van Gorp, ...
Gynecologic oncology 128 (1), 15-21, 2013
Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer
L Woelber, S Mahner, K Voelker, C ZU EULENBURG, F Gieseking, ...
Anticancer research 29 (2), 545-552, 2009
LION: Lymphadenectomy in ovarian neoplasms—A prospective randomized AGO study group led gynecologic cancer intergroup trial.
P Harter, J Sehouli, D Lorusso, A Reuss, I Vergote, C Marth, JW Kim, ...
Journal of Clinical Oncology 35 (15_suppl), 5500-5500, 2017
Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
X Meng, SA Joosse, V Müller, F Trillsch, K Milde-Langosch, S Mahner, ...
British journal of cancer 113 (9), 1358-1366, 2015
Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment
L Woelber, C Eulenburg, M Choschzick, A Kruell, C Petersen, F Gieseking, ...
International Journal of Gynecologic Cancer 22 (3), 503-508, 2012
Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer: a randomized multicenter phase II trial of the North-Eastern German …
J Sehouli, D Stengel, P Harter, C Kurzeder, A Belau, T Bogenrieder, ...
Journal of clinical oncology 29 (2), 242-248, 2011
Clinical management of primary vulvar cancer
L Woelber, L Kock, F Gieseking, C Petersen, F Trillsch, M Choschzick, ...
European journal of cancer 47 (15), 2315-2321, 2011
A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO …
E Pujade-Lauraine, S Mahner, J Kaern, V Gebski, M Heywood, P Vasey, ...
Journal of Clinical Oncology 27 (18_suppl), LBA5509-LBA5509, 2009
The system can't perform the operation now. Try again later.
Articles 1–20